Adicet Bio Appoints Dr. Andrew Sinclair to its Board of Directors

NEXT STORY
Ascendis Pharma A/S Announces Full Year 2020 Financial Results and Business Update Conference Call on March 10
PREV STORY
2020 Full-Year Results: Major advances in NASH and significantly extended cash runway through successful IPO in the United States
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Apellis Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of PNH

author_avatar
NASDAQ Market News

Amolyt Pharma Exercises Option to License Optimized Acromegaly Drug Candidate from PeptiDream as it Continues to Build its Rare Endocrine Pipeline

author_avatar
NASDAQ Market News

BriaCell Files Coronavirus Immunotherapy Patent

author_avatar
NASDAQ Market News